Market Place
Sourcing Support
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
16 Nov 2021 //
PHARMATIMES
EMA recommends Arvelle`s seizure drug cenobamate
01 Feb 2021 //
PHARMAFILE
Angelini acquires Arvelle to create a leading European innovator in CNS
14 Jan 2021 //
PRNEWSWIRE
Angelini Pharma acquires Arvelle Therapeutics
04 Jan 2021 //
PRESS RELEASE
Arvelle Announces Closing of Final Tranche of Series A Financing Round
27 Oct 2020 //
GLOBENEWSWIRE
Arvelle Announces Partnership with Durbin Across Europe
17 Aug 2020 //
GLOBENEWSWIRE
Results of a Randomised Study Showing that Adjunctive Cenobamate
21 May 2020 //
GLOBENEWSWIRE
Arvelle Announces European Medicines Agency Acceptance of the MAA for Cenobamate
26 Mar 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.